Article
Sofosbuvir induces gene expression for promoting cell proliferation and migration of hepatocellular carcinoma cells
12 Jul 2022
Abstract excerpt
Direct-acting antivirals (DAAs) have achieved a sustained virological response (SVR) rate of 95-99% in treating HCV. Several studies suggested that treatment with sofosbuvir (SOF), one type of DAAs, may be associated with increased risk of developing HCC. The aim of this study is to investigate the potential mechanisms of SOF on the development of HCC. OR-6 (harboring full-length genotype 1b HCV) and Huh 7.5.1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
